Determine Immunoglobulin G4 (IgG4) Standards for Cow's Milk and Egg in Different Populations of Allergic and Non-allergic Children
IgG4
2 other identifiers
observational
135
1 country
1
Brief Summary
The study objectives are : Determine standards of plasma levels of casein-specific immunoglobulin G4 (IgG4) and egg-specific immunoglobulin G4 (IgG4) as a function of age, in non-allergic children, in allergic children, and in cured former allergic patients. Analyze the plasma IgG4 / IgE ratio, according to the result of the oral provocation test (tolerance versus allergy) and, in the event of a reaction, according to the reactogenic dose (dose which caused the reaction).Determine whether analysis of the plasma metabolome can identify children with a cured allergy to cow's milk protein or to egg from those with a persistent allergy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2020
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 6, 2018
CompletedFirst Posted
Study publicly available on registry
December 14, 2018
CompletedStudy Start
First participant enrolled
November 17, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 19, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 19, 2023
CompletedApril 16, 2026
April 1, 2026
2.8 years
December 6, 2018
April 13, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Plasma concentration of casein-specific immunoglobulin G4 and egg-specific immunoglobulin G4
Day 0
Secondary Outcomes (7)
Plasma concentration of casein-specific immunoglobulin E and egg-specific immunoglobulin E
Day 0
Total immunoglobulin E plasma concentration
Day 0
Plasma concentration of casein-specific immunoglobulin G4 / plasma concentration of casein-specific immunoglobulin E ratio
Day 0
Plasma concentration of egg-specific immunoglobulin G4 / plasma concentration of egg-specific immunoglobulin E ratio
Day 0
Plasma concentration of casein-specific immunoglobulin G4 / total immunoglobulin E plasma concentration ratio
Day 0
- +2 more secondary outcomes
Study Arms (3)
Allergic
Minors allergic to cow's milk and/or eggs
Non-allergic
Minors without history of allergy to cow's milk and/or eggs
Acquired tolerance
Minors formerly allergic to cow's milk and/or eggs
Interventions
Patients less than 5 kg : 2 ml Patients over 5 kg : 3 ml Patients over 10 kg : 5 ml
Eligibility Criteria
Minors in consultation or hospitalized at Necker Hospital
You may qualify if:
- Minors aged 0 to 18
- In consultation or hospitalized for an oral food challenge for milk or eggs
- To undergo a blood test
You may not qualify if:
- Minors with immune deficiency, chronic inflammatory disease or immunosuppressive or immunomodulator treatment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hôpital Necker Enfants malades
Paris, 75015, France
Related Publications (1)
Adel-Patient K, Lezmi G, Castelli FA, Blanc S, Bernard H, Soulaines P, Dumond P, Ah-Leung S, Lageix F, de Boissieu D, Cortes-Perez N, Hazebrouck S, Fenaille F, Junot C, Dupont C. Deep analysis of immune response and metabolic signature in children with food protein induced enterocolitis to cow's milk. Clin Transl Allergy. 2018 Sep 28;8:38. doi: 10.1186/s13601-018-0224-9. eCollection 2018.
PMID: 30275944BACKGROUND
Biospecimen
Serum
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Guillaume Lezmi, MD, PhD
Assistance Publique - Hôpitaux de Paris
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 6, 2018
First Posted
December 14, 2018
Study Start
November 17, 2020
Primary Completion
September 19, 2023
Study Completion
September 19, 2023
Last Updated
April 16, 2026
Record last verified: 2026-04